Product Images Doxylamine Succinate And Phenylephrine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following image provide visual information about the product associated with Doxylamine Succinate And Phenylephrine Hydrochloride NDC 69367-199 by Westminster Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label - doxylamine 01
This is a drug facts sheet for Doxylamine Succinate and Phenylephrine HCI tablets, which are antihistamine nasal decongestants. The tablets can temporarily relieve symptoms such as nasal congestion, sneezing, itching of the throat, runny nose, and itchy, watery eyes caused by the common cold, hay fever, or allergies. However, anyone with heart disease, thyroid disease, high blood pressure, glaucoma, breathing problems such as emphysema or chronic bronchitis, or who is taking certain medications, should consult their doctor before using the product. Additionally, the tablets may cause drowsiness and excitability and should not be taken with alcohol or sedatives. The product should be kept out of the reach of children and medical attention should be sought in case of overdose. The recommended dosage is one tablet every four hours for adults and children over 12, not exceeding six tablets in 24 hours. For children between the ages of 6 and 12, the recommended dosage is half a tablet every four hours, not exceeding three tablets in 24 hours. Children under 6 should consult a physician before use.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.